News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
84,995 Results
Type
Article (3388)
Company Profile (17)
Press Release (81592)
Multimedia
Podcasts (11)
Webinars (2)
Section
Business (33499)
Career Advice (114)
Deals (5303)
Drug Delivery (9)
Drug Development (9887)
Employer Resources (9)
FDA (1764)
Job Trends (2083)
News (46033)
Policy (3355)
Tag
2027 Genetown Standard (1)
Academia (191)
Accelerated approval (12)
ADA (6)
Adcomms (3)
Allergies (31)
Alliances (2844)
ALS (21)
Alzheimer's disease (249)
Antibody-drug conjugate (ADC) (94)
Approvals (1913)
Artificial intelligence (62)
ASCO (178)
Autoimmune disease (67)
Automation (10)
Bankruptcy (32)
Best Places to Work (1877)
BIO (3)
Biologics (1)
BIOSECURE Act (1)
Biosimilars (37)
BioSpace Insights (8)
Biotechnology (11)
Bladder cancer (76)
Brain cancer (9)
Breast cancer (156)
Cancer (1232)
Cardiovascular disease (114)
Career advice (95)
Career pathing (4)
CAR-T (50)
CDC (3)
CDMO (10)
Celiac Disease (1)
Cell therapy (135)
Cervical cancer (14)
Clinical research (9677)
Collaboration (170)
Compensation (149)
Complete response letters (10)
COVID-19 (296)
CRISPR (10)
C-suite (96)
Cystic fibrosis (13)
Data (1883)
Denatured (4)
Depression (31)
Dermatology (17)
Diabetes (71)
Diagnostics (929)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (2)
Drug discovery (39)
Drug pricing (20)
Drug shortages (2)
Duchenne muscular dystrophy (39)
Earnings (27989)
Editorial (8)
Employer branding (2)
Employer resources (8)
Events (13285)
Executive appointments (73)
FDA (2582)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (150)
Gene editing (28)
Generative AI (7)
Gene therapy (98)
GLP-1 (158)
Government (437)
Grass and pollen (1)
Guidances (261)
Healthcare (2525)
Hematology (44)
HIV (43)
Huntington's disease (13)
IgA nephropathy (18)
Immunology and inflammation (51)
Immuno-oncology (11)
Indications (56)
Infectious disease (340)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (10)
Intellectual property (31)
Interviews (18)
IPO (3646)
IRA (4)
Job creations (275)
Job search strategy (85)
JPM (4)
Kidney cancer (5)
Labor market (23)
Layoffs (76)
Leadership (2)
Legal (588)
Licensing (4)
Liver cancer (20)
Longevity (3)
Lung cancer (203)
Lymphoma (120)
Machine learning (6)
Management (3)
Manufacturing (109)
Marketing (3)
MASH (58)
Medical device (1880)
Medtech (1911)
Mergers & acquisitions (1862)
Metabolic disorders (252)
mRNA (24)
Multiple sclerosis (55)
NASH (7)
Neurodegenerative disease (61)
Neuropsychiatric disorders (11)
Neuroscience (501)
NextGen: Class of 2026 (622)
Non-profit (380)
Now hiring (8)
Obesity (104)
Opinion (16)
Ovarian cancer (35)
Pain (45)
Pancreatic cancer (68)
Parkinson's disease (25)
Partnered (2)
Patents (71)
Patient recruitment (75)
Peanut (6)
People (3061)
Peptides (1)
Pharmaceutical (4)
Pharmacy benefit managers (6)
Phase 1 (2388)
Phase 2 (3950)
Phase 3 (4095)
Pipeline (2963)
Policy (22)
Postmarket research (369)
Preclinical (719)
Press Release (3)
Prostate cancer (75)
Psychedelics (6)
Radiopharmaceuticals (41)
Rare diseases (169)
Real estate (313)
Recruiting (4)
Regulatory (3130)
Reports (16)
Research institute (185)
Resumes & cover letters (18)
Rett syndrome (12)
RNA editing (4)
RSV (16)
Schizophrenia (27)
Series A (18)
Series B (13)
Service/supplier (1)
Sickle cell disease (19)
Special edition (5)
Spinal muscular atrophy (24)
Sponsored (3)
Startups (178)
Stomach cancer (5)
Supply chain (9)
Tariffs (9)
The Weekly (7)
Vaccines (121)
Venture capital (8)
Weight loss (70)
Women's health (19)
Worklife (2)
Date
Today (7)
Last 7 days (68)
Last 30 days (308)
Last 365 days (5218)
2026 (3643)
2025 (5275)
2024 (5977)
2023 (5653)
2022 (6970)
2021 (7088)
2020 (7054)
2019 (5430)
2018 (3801)
2017 (3292)
2016 (3357)
2015 (4280)
2014 (2814)
2013 (1884)
2012 (2374)
2011 (2517)
2010 (2483)
Location
Africa (74)
Alabama (15)
Alaska (2)
Arizona (50)
Arkansas (2)
Asia (5258)
Australia (680)
California (2647)
Canada (756)
China (248)
Colorado (107)
Connecticut (103)
Delaware (127)
Europe (12354)
Florida (314)
Georgia (65)
Hawaii (1)
Idaho (3)
Illinois (206)
India (14)
Indiana (138)
Iowa (1)
Japan (124)
Kansas (16)
Kentucky (11)
Louisiana (13)
Maine (20)
Maryland (292)
Massachusetts (1776)
Michigan (50)
Minnesota (133)
Mississippi (1)
Missouri (18)
Montana (5)
Nebraska (1)
Nevada (20)
New Hampshire (20)
New Jersey (944)
New Mexico (2)
New York (674)
North Carolina (316)
North Dakota (2)
Northern California (1402)
Ohio (65)
Oregon (3)
Pennsylvania (506)
Puerto Rico (7)
Rhode Island (4)
South America (124)
South Carolina (9)
Southern California (1049)
Tennessee (28)
Texas (346)
United States (9077)
Utah (76)
Virginia (29)
Washington D.C. (4)
Washington State (230)
West Virginia (1)
Wisconsin (16)
84,995 Results for "29".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biovica Resolves on a Fully Guaranteed Rights Issue of SEK 29.2 Million
September 9, 2026
·
24 min read
Mergers & acquisitions
Deal-hungry Lilly strikes up to $2.9B immuno play for Merida
With the acquisition of Merida Biosciences, Eli Lilly is gaining a precision degradation platform for therapies that selectively target and destroy pathologic antibodies for allergic and autoimmune diseases.
August 31, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Guardant Health to Participate in Upcoming Investor Conferences - July 29, 2026
July 29, 2026
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
August 18, 2026
·
2 min read
Press Releases
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
July 20, 2026
·
3 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - June 29, 2026
June 29, 2026
·
2 min read
Press Releases
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
July 7, 2026
·
1 min read
Press Releases
GE HealthCare to announce second quarter 2026 results on July 29, 2026
July 8, 2026
·
1 min read
Press Releases
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
July 6, 2026
·
1 min read
Press Releases
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
July 16, 2026
·
1 min read
1 of 8,500
Next
